Rosalind Advisors, Inc.
Source: SEC Form 13F · as of Mar 2026Rosalind Advisors, Inc. holds 19 biotech & pharma companies tracked by BioSniper, totaling $130.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$130.1M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Xeris Biopharma Holdings, Inc. (XERS)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| XERSXeris Biopharma Holdings, Inc. | 3,231,700 | $18.7M |
| FENCFENNEC PHARMACEUTICALS INC. | 2,908,201 | $17.9M |
| SVRASavara Inc | 3,203,721 | $17.5M |
| PCVXVaxcyte, Inc. | 290,000 | $16.9M |
| XFORX4 Pharmaceuticals, Inc | 3,214,766 | $13.3M |
| MDWDMediWound Ltd. | 749,054 | $12.1M |
| CLDXCelldex Therapeutics, Inc. | 330,000 | $10.5M |
| VRDNViridian Therapeutics, Inc.\DE | 250,401 | $4.9M |
| PYPDPolyPid Ltd. | 597,926 | $2.6M |
| TLPHTALPHERA, INC. | 3,353,916 | $2.5M |
| OVIDOvid Therapeutics Inc. | 1,107,994 | $2.5M |
| DFTXDefinium Therapeutics Inc. | 125,000 | $2.4M |
| OKUROnKure Therapeutics, Inc. | 443,763 | $1.8M |
| LPCNLipocine Inc. | 221,616 | $1.8M |
| AVTXAvalo Therapeutics, Inc. | 75,000 | $1.1M |
| ANNXAnnexon, Inc. | 200,000 | $1.1M |
| AQSTAquestive Therapeutics, Inc. | 250,000 | $1.0M |
| KURAKura Oncology, Inc. | 100,000 | $813K |
| RGNTRegentis Biomaterials Ltd. | 251,510 | $768K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.